Gyre Therapeutics Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Gyre Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $18.67. The average 1-year stock price forecast is 206.07% higher than the current stock price, while the lowest is $18 (+195.08%) and the highest is $20 (+227.87%).

Price Target: $18.67 (+206.07%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$18	$18.67	$18	$20
Change	+195.08%	+206.07%	+195.08%	+227.87%

* Price targets were last updated on May 8, 2026.

Analyst Ratings

The average analyst rating for Gyre Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Jan '26	Mar '26	May '26	Jun '26
Strong Buy	2	3	3	3	3	3
Buy	1	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert LeBoyer Noble Financial	Noble Financial	Buy Reiterates $20	Buy	Reiterates	$20	+227.87%	May 8, 2026
Matthew Keller H.C. Wainwright	H.C. Wainwright	Buy Reiterates $18	Buy	Reiterates	$18	+195.08%	May 7, 2026

Financial Forecast

Revenue This Year

102.30M

from 116.59M

-12.26%

from 116.59M

Revenue Next Year

130.75M

from 102.30M

27.81%

from 102.30M

EPS This Year

-0.02

from 0.18

EPS Next Year

0.06

from -0.02

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	102.29M	113.45M	105.76M	116.59M	102.30M
Revenue Growth	-	10.91%	-6.78%	10.24%	-12.26%
Gross Profit	97.50M	108.81M	101.87M	111.17M	96.16M
Gross Margin	95.31%	95.91%	96.33%	95.35%	94.00%
Operating Income	9.20M	19.21M	16.23M	11.49M	-19.05M
Net Income	2.30M	-92.93M	12.09M	5.03M	-19.15M
EPS	-	-	-	0.18	-0.02
Free Cash Flow	-	20.67M	-6.00M	1.95M	35.00M
No. Analysts	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	106.0M
Avg	102.3M
Low	98.9M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-9.1%
Avg	-12.3%
Low	-15.2%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.02
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-